TargetMol

Aclacinomycin

Product Code:
 
TAR-T23617
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T23617-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Aclacinomycin A is an anthracycline drug. It sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation. It is used in the treatment of cancer.
CAS:
66676-88-8
Formula:
C30H35NO10
Molecular Weight:
569.61
Purity:
0.98
SMILES:
OC1=CC=CC2=C1C(C3=C(O)C([C@@H](O[C@H]4C[C@H](N(C)C)[C@H](O)[C@H](C)O4)C[C@](O)(CC)[C@@H]5C(OC)=O)=C5C=C3C2=O)=O

References

1. Bundale S, Begde D, Pillai D, Gangwani K, Nashikkar N, Kadam T, Upadhyay A. Novel aromatic polyketides from soil Streptomyces spp.: purification, characterization and bioactivity studies. World J Microbiol Biotechnol. 2018 Apr 24;34(5):67. doi: 10.1007/s11274-018-2448-1. PubMed PMID: 29691661. 2. Lee YL, Chen CW, Liu FH, Huang YW, Huang HM. Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation. PLoS One. 2017 Oct 11;12(10):e0186528. doi: 10.1371/journal.pone.0186528. eCollection 2017. PubMed PMID: 29020096; PubMed Central PMCID: PMC5636156. 3. Ye YB, Xu XJ, Chen YH, Zhang MW, Qiu DF, Guo ZW, He HQ. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a]. Zhonghua Zhong Liu Za Zhi. 2017 Apr 23;39(4):256-262. doi: 10.3760/cma.j.issn.0253-3766.2017.04.004. Chinese. PubMed PMID: 28550664. 4. Sakai T, Miyazaki T, Shin DM, Kim YS, Qi CF, Fariss R, Munasinghe J, Wang H, Kovalchuk AL, Kothari PH, Fermaintt CS, Atkinson JP, Perrino FW, Yan N, Morse HC 3rd. DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice. J Autoimmun. 2017 Jul;81:13-23. doi: 10.1016/j.jaut.2017.03.001. Epub 2017 Mar 18. PubMed PMID: 28325644; PubMed Central PMCID: PMC5558601.